The progress of a new in vitro pyrogen test

HE Kai-yong,GAO Hua,JI Hui
2007-01-01
Abstract:It is a requirement that parenteral medicines or biological products and embedded medical devices be free of pyrogens.All pharmacopoeia use one of two animal-based tests:the rabbit pyrogen test and the BET present,but there are some problems to them.When human monocytic cells are stimulated by exogenous pyrogens in circulation, they will release proinflammatory cytokines (such as IL-1β,IL- 6,TNF-α,IFN-λ,et al)i.e.endogenous pyro- gens.These cytokines transmit signals to increase the thermostatic set point and trigger to increase the body tempera- ture,the content of cytokines can be measured using ELISA.The new in vitro pyrogen test system is based on that. The new method combines the high sensitivity of the BET with the wide range of pyrogens detectable by the rabbit pyrogen test.In comparison with the rabbite pyrogen test,the new method is more sensitive,less expensive and re- fleets the human reaction to the pyrogen directly.Compared to bacterial endotoxin test,the new method is not re- stricted to endotoxins of gram-negative bacteria.In Europe,there are six most prominent test systems were formally validated,evidence indicated they are safer,animal -free and more efficient pyrogen detection system and they are suitable for introduction to regulatory acceptance and pharmacopoeia.
What problem does this paper attempt to address?